SELVITA SA


Cracow biotechnology company operates in the discovery and development of drugs for the treatment of neoplastic diseases, central nervous system diseases and autoimmune diseases. It also provides comprehensive solutions in the field of chemistry, biotechnology and bioinformatics for research and development units and various industries. In the area of cancer research the company cooperates with reputable foreign companies H3 Biomedicine, Merck Serono and Felicitex Therapeutics.